JWM
EBS icon

Janiczek Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Janiczek Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40
Closed -$2K – 977
2022
Q1 		$2K Sell
40
-109
-73% -$4.81K ﹤0.01% 762
2021
Q4 		$6K Buy
149
+3
+2% +$136 ﹤0.01% 663
2021
Q3 		$7K Buy
146
+68
+87% +$4.12K ﹤0.01% 630
2021
Q2 		$5K Buy
78
+59
+311% +$3.79K ﹤0.01% 661
2021
Q1 		$2K Sell
19
-16
-46% -$1.64K ﹤0.01% 730
2020
Q4 		$3K Buy
35
+4
+13% +$367 ﹤0.01% 648
2020
Q3 		$3K Buy
+31
New +$3.34K ﹤0.01% 433

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janiczek Wealth Management's EBS Position: Q2 2022 in Review

Janiczek Wealth Management sold out of Emergent Biosolutions (EBS) in Q2 2022, closing a stake of 40 shares — an estimated $2K sold.

Janiczek Wealth Management first reported a position in EBS in Q3 2020 and held it in 7 quarters. The position peaked at $7K in Q3 2021. 232 funds tracked by Wall St. Rank hold EBS as of Q2 2022.

  • Janiczek Wealth Management reported no remaining Emergent Biosolutions position as of Q2 2022 after selling out during the quarter.
  • Janiczek Wealth Management sold 40 Emergent Biosolutions shares in Q2 2022, an estimated $2K.
  • Janiczek Wealth Management first reported a position in Emergent Biosolutions in Q3 2020 and held it in 7 quarters.
  • Janiczek Wealth Management's Emergent Biosolutions position peaked at $7K in Q3 2021.
  • 232 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2022.

Based on Janiczek Wealth Management's 13F filing for Q2 2022, filed 3 Aug 2022.